Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing

Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing

Parenteral prostanoids are being recommended in pulmonary arterial hypertension (PAH) treatment, but the prognostic relevance of delayed treatment initiation is still debated. This study assessed the impact of the timing of prostacyclin treatment initiation on reducing PVR and achieving a low-risk p...

Full description

Bibliographic Details
Main Authors: Silvia Papa, Gianmarco Scoccia, Giorgia Serino, Francesca Ileana Adamo, Jean Pierre Jabbour, Annalisa Caputo, Michela Boromei, Domenico Filomena, Domenico Laviola, Enrico Maggio, Giovanna Manzi, Alexandra Mihai, Tommaso Recchioni, Alexandra Sabusco, Livia Valeri, Sara Vinciullo, Carmine Dario Vizza, Roberto Badagliacca
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Journal of Clinical Medicine
Subjects:
pulmonary arterial hypertension
pulmonary vascular resistance
reverse remodeling
prostanoids
Online Access:https://www.mdpi.com/2077-0383/12/21/6840

Internet

https://www.mdpi.com/2077-0383/12/21/6840

Similar Items